CDXS insider buying and SEC filings, explained
Codexis, Inc. · CIK 1200375
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.2M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 12, 2026 | Sale | Georgia Erbez (CFO) sold 6,335 shares at $1.36 ($9K). Holdings down 9% to 60,475 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 5:19 PM ET |
| Oct 12, 2026 | Sale | Alison Moore (CEO and Director) sold 6,335 shares at $1.36 ($9K). Holdings down 3% to 244,171 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 5:17 PM ET |
| Jun 11, 2026 | Sale | Vre Raymond De (Director) sold 2,605 shares at $2.37 ($6K). Holdings down 3% to 84,811 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 11, 2026 |
| Feb 24, 2026 | Sale | Stefan Lutz (Chief Scientific Officer) sold 5,862 shares at $1.13 ($7K). Holdings down 4% to 130,421 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 6, 2026 | Sale | Stefan Lutz (Chief Scientific Officer) sold 2,492 shares at $1.31 ($3K). Holdings down 2% to 136,283 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 9, 2026 |
| Feb 6, 2026 | Sale | Georgia Erbez (CFO) sold 3,826 shares at $1.31 ($5K). Holdings down 5% to 66,810 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 9, 2026 |
| Feb 6, 2026 | Sale | Alison Moore (CEO and Director) sold 3,826 shares at $1.31 ($5K). Holdings down 2% to 250,506 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 9, 2026 |
| Jan 7, 2026 | Sale | Stefan Lutz (CSO) sold 4,685 shares at $1.70 ($8K). Holdings down 3% to 138,775 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Nov 26–Dec 1, 2025 | Sale Amended filing | Opaleye Management Inc. (10% owner) sold 514,341 shares indirectly (by entity) between Nov 26, 2025 and Dec 1, 2025 at about $1.71 ($878K). Holdings by entity down 5% to 9,955,000 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Dec 1, 2025. | SEC filing Filed Dec 15, 2025 |
| Nov 7–11, 2025 | Sale Amended filing | Opaleye Management Inc. (10% owner) sold 1,063,211 shares indirectly (by entity) between Nov 7, 2025 and Nov 11, 2025 at about $1.76 ($1.9M). Holdings by entity down 8% to 11,508,318 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Nov 12, 2025. | SEC filing Filed Dec 15, 2025 |
| Nov 21, 2025 | Sale | Dennis P. Wolf (Director) sold 8,952 shares at about $1.56 ($14K). Holdings down 6% to 138,951 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 12, 2025 | Sale | Opaleye Management Inc. (10% owner) sold 192,459 shares indirectly (by entity) at about $1.96 ($377K). Holdings by entity down 2% to 10,453,318 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 14, 2025 |
| Nov 11, 2025 | Sale | Vre Raymond De (Director) sold 1,413 shares at $1.74 ($2K). Holdings down 2% to 87,416 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 13, 2025 |
14 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CDXS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.